CENCORA, INC. Segment Expenditure Addition To Long Lived Assets
CENCORA, INC. (COR) reported Segment Expenditure Addition To Long Lived Assets of $226.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-08-05
- CENCORA, INC. segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $226.04M, a 23.37% increase year-over-year.
- CENCORA, INC. segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $165.62M, a 28.33% increase year-over-year.
- CENCORA, INC. segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $119.38M, a 12.73% increase year-over-year.
- CENCORA, INC. segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $249.81M.
- CENCORA, INC. segment expenditure addition to long lived assets for fiscal 2022 was $496.32M, a 13.26% increase from fiscal 2021.
- CENCORA, INC. segment expenditure addition to long lived assets for fiscal 2021 was $438.22M.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $226.04M 10-Q · filed 2026-08-05 | $391.66M derived: sum of 2 quarters · filed 2026-08-05 | $511.03M 10-Q · filed 2026-08-05 | $760.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $165.62M 10-Q · filed 2026-05-06 | $284.99M 10-Q · filed 2026-05-06 | $534.81M derived: sum of 3 quarters · filed 2026-05-06 | $718.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $119.38M 10-Q · filed 2026-02-04 | $369.19M derived: sum of 2 quarters · filed 2026-02-10 | $552.40M derived: sum of 3 quarters · filed 2026-08-05 | $681.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-09-30 | $249.81M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $433.03M derived: sum of 2 quarters · filed 2026-08-05 | $562.09M derived: sum of 3 quarters · filed 2026-08-05 | $667.98M 8-K · filed 2026-02-10 |
| 2025-06-30 | $183.22M 10-Q · filed 2026-08-05 | $312.28M derived: sum of 2 quarters · filed 2026-08-05 | $418.17M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $129.06M 10-Q · filed 2026-05-06 | $234.95M 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $105.89M 10-Q · filed 2026-02-04 | |||
| 2024-09-30 | $487.17M 8-K · filed 2026-02-10 | |||
| 2023-09-30 | $458.36M 8-K · filed 2026-02-10 | |||
| 2022-09-30 | $496.32M 10-K · filed 2024-11-26 | |||
| 2021-09-30 | $438.22M 10-K · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |